In the continuous effort to comply with USP and The Joint Commission's National Patient Safety Goals, pharmacists are seeking products that save time and labor while maximizing patient safety. Ready-to-use IV products are often cited as a means to meet those ends, as they eliminate the need to perform compounding and, therefore, can reduce the potential for medication errors and product contamination. To help you increase efficiency and improve patient safety, PP&P presents the following resource for finding ready-to-use IV products.
Digital Edition
PP&P is now available online in the exact layout and appearance of the print edition, and includes more interactive features, such as the ability to access websites and request information with the click of a mouse. To view this article in the digital edition, CLICK HERE.
- 1 - 100
- 101 - 200
- 201 - 300
- 301 - 400
- 400+
- April 2012 : State of Pharmacy Compounding
Survey Respondents: BONUS DATA - April 2012 : State of Pharmacy Compounding
<797> Compliance: BONUS DATA - April 2012 : State of Pharmacy Compounding
Ready-to-Use IV Products: BONUS DATA - April 2012 : State of Pharmacy Compounding
Budgeting and Renovation: BONUS DATA - May 2012
Managing NDC and Product Changes

- In The Loop!
- Digital Edition
- Special Announcements









Our mission is to provide health system pharmacists with information to streamline pharmacy operations and promote patient safety.